These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28883402)

  • 21. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
    Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
    Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
    Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
    Halls ML; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
    Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
    J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor.
    Valkovic AL; Leckey MB; Whitehead AR; Hossain MA; Inoue A; Kocan M; Bathgate RAD
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00432. PubMed ID: 30263124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
    Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
    Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases.
    Mallart S; Ingenito R; Bianchi E; Bresciani A; Esposito S; Gallo M; Magotti P; Monteagudo E; Orsatti L; Roversi D; Santoprete A; Tucci F; Veneziano M; Bartsch R; Boehm C; Brasseur D; Bruneau P; Corbier A; Froissant J; Gauzy-Lazo L; Gervat V; Marguet F; Menguy I; Minoletti C; Nicolas MF; Pasquier O; Poirier B; Raux A; Riva L; Janiak P; Strobel H; Duclos O; Illiano S
    J Med Chem; 2021 Feb; 64(4):2139-2150. PubMed ID: 33555858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
    Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
    Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology.
    Agoulnik IU; Kaftanovskaya EM; Myhr C; Bathgate RAD; Kocan M; Peng Y; Lindsay RM; DiStefano PS; Agoulnik AI
    Biochem Pharmacol; 2024 Jun; 227():116401. PubMed ID: 38945278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
    Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
    J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
    Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
    Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of RXFP1 in skin of scleroderma patients and control subjects.
    Giordano N; Volpi N; Franci D; Corallo C; Fioravanti A; Papakostas P; Montella A; Biagioli M; Fimiani M; Grasso G; Muscettola MM; Guerranti R; Vannoni D; Galeazzi M; Nuti R
    Scand J Rheumatol; 2012 Oct; 41(5):391-5. PubMed ID: 23043266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
    Singh S; Bennett RG
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
    J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
    Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
    Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
    Callander GE; Thomas WG; Bathgate RA
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.